Những nghiên cứu phân tích về COVID-19 (ngày 25/2

PUBMED

1. The coronavirus disease (COVID-19) - A supportive approach with selected micronutrients.

Gröber U, Holick MF.

Int J Vitam Nutr Res. 2022 Jan;92(1):13-34. doi: 10.1024/0300-9831/a000693. Epub 2021 Jan 25.

PMID: 33487035

https://econtent.hogrefe.com/doi/epdf/10.1024/0300-9831/a000693

2. COVID-19 vaccination intention in the first year of the pandemic: A systematic review.

Al-Amer R, Maneze D, Everett B, Montayre J, Villarosa AR, Dwekat E, Salamonson Y.

J Clin Nurs. 2022 Jan;31(1-2):62-86. doi: 10.1111/jocn.15951. Epub 2021 Jul 6.

PMID: 34227179

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447353/pdf/JOCN-9999-0.pdf

3. COVID-19 diagnosis using state-of-the-art CNN architecture features and Bayesian Optimization.

Aslan MF, Sabanci K, Durdu A, Unlersen MF.

Comput Biol Med. 2022 Mar;142;105244. doi: 10.1016/j.compbiomed.2022.105244. Epub 2022 Jan 20.

PMID: 35077936

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770389/pdf/main.pdf

4. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis.

Sotoodeh Ghorbani S, Taherpour N, Bayat S, Ghajari H, Mohseni P, Hashemi Nazari SS.

J Med Virol. 2022 Jan;94(1):44-53. doi: 10.1002/jmv.27281. Epub 2021 Aug 27.

PMID: 34411311

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507360/pdf/10903_2021_Article_1290.pdf

5. In-line treatments and clinical initiatives to fight against COVID-19 outbreak.

Agrawal M, Saraf S, Saraf S, Murty US, Kurundkar SB, Roy D, Joshi P, Sable D, Choudhary YK, Kesharwani P, Alexander A.

Respir Med. 2022 Jan; 191:106192. doi: 10.1016/j.rmed.2020.106192. Epub 2020 Oct 17.

PMID: 33199136

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567661/pdf/main.pdf

6. COVID-19 Radiology Preparedness, Challenges & Opportunities: Responses From 18 Countries.

Rehani B, Rodriguez JA, Nguyen JK, Patel MM, Ammanuel SG, Winford E, Dillon WP.

Curr Probl Diagn Radiol. 2022 Mar-Apr;51(2):196-203. doi: 10.1067/j.cpradiol.2021.03.017. Epub 2021 Apr 24.

PMID: 33994227

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064895/pdf/main.pdf

7. Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees.

James AE, Gulley T, Kothari A, Holder K, Garner K, Patil N.

Infect Control Hosp Epidemiol. 2022 Jan;43(1):99-101. doi: 10.1017/ice.2021.20. Epub 2021 Jan 25.

PMID: 33487197

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870908/pdf/S0899823X21000209a.pdf

8. Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers.

McFadden DD, Bornstein SL, Vassallo R, Salonen BR, Bhuiyan MN, Schroeder DR, Croghan IT.

J Prim Care Community Health. 2022 Jan-Dec;13:21501319211062672. doi: 10.1177/21501319211062672.

PMID: 34986700

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744181/pdf/10.1177_21501319211062672.pdf

9. Review and classification of AI-enabled COVID-19 CT imaging models based on computer vision tasks.

Hassan H, Ren Z, Zhao H, Huang S, Li D, Xiang S, Kang Y, Chen S, Huang B.

Comput Biol Med. 2022 Feb;141:105123. doi: 10.1016/j.compbiomed.2021.105123. Epub 2021 Dec 18.

PMID: 34953356

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684223/pdf/main.pdf

10. COVID-19 diagnostics: preserving manufacturing capacity for future pandemics.

Hannay E, Fernández-Suárez M, Duneton P.

BMJ Glob Health. 2022 Feb;7(2):e007494. doi: 10.1136/bmjgh-2021-007494.

PMID: 35149552

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844951/pdf/bmjgh-2021-007494.pdf

11. Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics.

Zhou Y, Zhang L, Xie YH, Wu J.

Lab Invest. 2022 Jan;102(1):4-13. doi: 10.1038/s41374-021-00663-w. Epub 2021 Sep 8.

PMID: 34497366

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424153/pdf/41374_2021_Article_663.pdf

12. Mental health status of COVID-19 survivors: a cross sectional study.

Jafri MR, Zaheer A, Fatima S, Saleem T, Sohail A.

Virol J. 2022 Jan 6;19(1):3. doi: 10.1186/s12985-021-01729-3.

PMID: 34991632

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733909/pdf/12985_2021_Article_1729.pdf

13. Analyzing COVID-19 Vaccination Behavior Using an SEIRM/V Epidemic Model With Awareness Decay.

Zuo C, Zhu F, Ling Y.

Front Public Health. 2022 Jan 27;10:817749. doi: 10.3389/fpubh.2022.817749. eCollection 2022.

PMID: 35155327

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829349/pdf/fpubh-10-817749.pdf

14. Why Physical Activity Should Be Considered in Clinical Trials for COVID-19 Vaccines: A Focus on Risk Groups.

Bortolini MJS, Petriz B, Mineo JR, Resende RO.

Int J Environ Res Public Health. 2022 Feb 7;19(3):1853. doi: 10.3390/ijerph19031853.

PMID: 35162875

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834774/pdf/ijerph-19-01853.pdf

15. Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.

Raw RK, Rees J, Kelly CA, Wroe C, Chadwick DR.

Vaccine. 2022 Jan 24;40(3):418-423. doi: 10.1016/j.vaccine.2021.11.090. Epub 2021 Dec 4.

PMID: 34895935

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642150/pdf/main.pdf

16. Justifying the risks of COVID-19 challenge trials: The analogy with organ donation.

Jayaram A, Sparks J, Callies D.

Bioethics. 2022 Jan;36(1):100-106. doi: 10.1111/bioe.12889. Epub 2021 Jun 27.

PMID: 34180072

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444865/pdf/BIOE-9999-0.pdf

SCIENCEDIRECT

1. Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?

Clinical Immunology Communications, 23 December 2021, Volume 2 (Cover date: December 2022), Pages 1-5

Zafran Khan, Ubaid Ahmad, Nasib Zaman
https://www.sciencedirect.com/science/article/pii/S2772613421000147/pdfft?md5=f005b5e6811cb9abe9678febb5aa3d6a&pid=1-s2.0-S2772613421000147-main.pdf

2. RCSB Protein Data Bank resources for structure-facilitated design of mRNA vaccines for existing and emerging viral pathogens
Structure, 4 November 2021, Volume 30, Issue 1 (Cover date: 6 January 2022), Pages 55-68.e2

David S. Goodsell, Stephen K. Burley

https://www.sciencedirect.com/science/article/pii/S0969212621003762/pdfft?md5=2362927393c4561d49ade893b3a363e1&pid=1-s2.0-S0969212621003762-main.pdf

3. Isothermal gene amplification coupled MALDI-TOF MS for SARS-CoV-2 detection

Talanta, 8 February 2022, Volume 242 (Cover date: 15 May 2022), Article 123297

Guobin Han, Qiuyuan Lin, Liang Qiao
https://www.sciencedirect.com/science/article/pii/S0039914022000935/pdfft?md5=8f165b28cdd4a99fcf9a164a921ae2e7&pid=1-s2.0-S0039914022000935-main.pdf

4. Immune responses to human respiratory coronaviruses infection in mouse models
Current Opinion in Virology, 11 December 2021, Volume 52 (Cover date: February 2022), Pages 102-111

Zhen Zhuang, Donglan Liu, Jincun Zhao

https://www.sciencedirect.com/science/article/pii/S1879625721001565/pdfft?md5=7c5a92231b080e575bbb3ea8bad21656&pid=1-s2.0-S1879625721001565-main.pdf

5. Clinical features and mechanistic insights into drug repurposing for combating COVID-19

The International Journal of Biochemistry & Cell Biology, 5 November 2021, Volume 142 (Cover date: January 2022), Article 106114

Purva Asrani, Keshav Tiwari, Sukhwinder Singh Sohal
https://www.sciencedirect.com/science/article/pii/S1357272521001953/pdfft?md5=76d0589ff5d346d116450b5eb9398db6&pid=1-s2.0-S1357272521001953-main.pdf

6. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals

Journal of Allergy and Clinical Immunology, Available online 21 January 2022, In press, corrected proof

Min Li, Jiaojiao Liu, Xia Jin
https://www.sciencedirect.com/science/article/pii/S0091674922000732/pdfft?md5=f754a0facc897afd8f93e06c1c620447&pid=1-s2.0-S0091674922000732-main.pdf

7. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status

Vaccine, 3 December 2021, Volume 40, Issue 3 (Cover date: 24 January 2022), Pages 531-535

François Helle, Julien Moyet, Etienne Brochot
https://www.sciencedirect.com/science/article/pii/S0264410X21015589/pdfft?md5=86908ab28df9794e218c8dcfc3979ebb&pid=1-s2.0-S0264410X21015589-main.pdf

8. Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
Biosafety and Health, Available online 3 January 2022, In press, corrected proof

Sheng Wang, Lizhen Liu, Hong Shao

https://www.sciencedirect.com/science/article/pii/S2590053621001269/pdfft?md5=a5a5258a5e01f2835032ece3498a7087&pid=1-s2.0-S2590053621001269-main.pdf

9. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
Human Immunology, 8 September 2021, Volume 83, Issue 1 (Cover date: January 2022), Pages 86-98

Mehran Ghasemzadeh, Alireza Ghasemzadeh, Ehteramolsadat Hosseini

https://www.sciencedirect.com/science/article/pii/S0198885921002305/pdfft?md5=158972f8afc98ec907424a6c4bf599f4&pid=1-s2.0-S0198885921002305-main.pdf

10. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Virus Research, 14 November 2021, Volume 308 (Cover date: 15 January 2022), Article 198631

Sujay Paul, Luis Alberto Bravo Vázquez, Aashish Srivastava

https://www.sciencedirect.com/science/article/pii/S0168170221003385/pdfft?md5=f57b4fa55d64cb501aa7ee9ca1f32c4e&pid=1-s2.0-S0168170221003385-main.pdf

11. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review
Annals of Oncology, 28 October 2021, Volume 33, Issue 2 (Cover date: February 2022), Pages 158-168

C. Corti, G. Antonarelli, G. Curigliano
https://www.sciencedirect.com/science/article/pii/S0923753421045506/pdfft?md5=1ebb3081fc3dadd6084d475de21ca114&pid=1-s2.0-S0923753421045506-main.pdf

12. Probing the formation, structure and free energy relationships of M protein dimers of SARS-CoV-2

Computational and Structural Biotechnology Journal, 11 January 2022, Volume 20 (Cover date: 2022), Pages 573-582

Yipeng Cao, Rui Yang, Zhiyong Yuan

https://www.sciencedirect.com/science/article/pii/S2001037022000149/pdfft?md5=01f3be50d0558f8fd6173cc2c9d34e89&pid=1-s2.0-S2001037022000149-main.pdf

WILEY

1. Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach

Dr. Milan Sencanski,Dr. Vladimir Perovic,Dr. Jelena Milicevic,Dr. Tamara Todorovic,Dr. Radivoje Prodanovic,Dr. Veljko Veljkovic,Dr. Slobodan Paessler,Dr. Sanja Glisic

First published: 01 February 2022

https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/open.202100248

2. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation

Liang-Chang Hu,Chuan-Hua Ding,Hong-Ying Li,Zhen-Zhen Li,Ying Chen,Li-Peng Li,Wan-Zhong Li,Wen-Shan Liu

First published: 06 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/jfbc.14085

3. SARS-CoV-2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion

Federica Quaglia,Edoardo Salladini,Marco Carraro,Giovanni Minervini,Silvio C.E. Tosatto,Philippe Le Mercier

First published: 02 February 2022

https://febs.onlinelibrary.wiley.com/doi/epdf/10.1111/febs.16379

4. Persistence of Ad26.COV2.S-associated VITT and specific detection of VITT antibodies

Adam J. Kanack PhD,Bandana Singh PhD,Gemlyn George MBBS,Krishna Gundabolu MBBS MS,Scott A. Koepsell MD PhD,Mouhamed Yazan Abou-Ismail MD,Karen A. Moser MD

First published: 07 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.26488

5. A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA-dependent RNA polymerase of wild-type and Delta subvariant AY.4 of SARS-CoV-2

Ismail Celik,Trina E. Tallei

First published: 07 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcb.30226

6. Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes

Sandra Gray-Rodriguez,Melanie P. Jensen,Maria Otero-Jimenez,Brian Hanley,Olivia C. Swann,Patrick A. Ward,Francisco J. Salguero,Nadira Querido,Ildiko Farkas,Elisavet Velentza-Almpani …

First published: 02 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/path.5878

7. Successful Early Use of Anti-SARS-CoV-2 Monoclonal Neutralizing Antibodies in SARS-CoV-2 Infected Hematological Patients – A Czech Multicenter Experience

Barbora Weinbergerová,Ivo Demel,Benjamin Víšek,Jan Válka,Martin Čerňan,Pavel Jindra,Jan Novák,Lukáš Stejskal,Flóra Kovácsová,Tomáš Kabut,Tomáš Szotkowski,Roman Hájek …

First published: 04 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.2974

8. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant

Dandan Tian,Yanhong Sun,Huihong Xu,Qing Ye

First published: 03 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27643

9. Comparing humoral immune response to SARS-CoV2 vaccines in multiple sclerosis and healthy controls: an Austrian prospective multi-center cohort study

Gabriel Bsteh,Harald Hegen,Gerhard Traxler,Nik Krajnc,Fritz Leutmezer,Franziska Di Pauli,Barbara Kornek,Paulus Rommer,Gudrun Zulehner,Sophie Dürauer,Angelika Bauer …

First published: 01 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ene.15265

10. Clinical impact and benefits of a simultaneous cardio-pulmonary rehabilitation in a COVID-19-infected patient following cardiac arrest: A case report

Mirim Lee,Jeong Jae Lee,Jun young Ko,Yong Kyun Kim,Seungbok Lee

First published: 02 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.5345

SPRINGER NATURE

1. Pre-COVID-19 Social Determinants of Health Among Mexican Migrants in Los Angeles and New York City and Their Increased Vulnerability to Unfavorable Health Outcomes During the COVID-19 Pandemic

Mireya Vilar-Compte, Pablo Gaitán-Rossi… in Journal of Immigrant and Minority Health (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10903-021-01283-8.pdf

2. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months

Fatih Karaarslan, Fulya Demircioğlu Güneri, Sinan Kardeş in Clinical Rheumatology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10067-021-05942-x.pdf

3. Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register

Daniela Poli, Emilia Antonucci, Walter Ageno… in Internal and Emergency Medicine (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11739-021-02891-w.pdf

4. Applications of nanomaterials in COVID-19 pandemic

Mei-Fang Xiao, Chang Zeng, Shao-Hui Li, Fu-Lai Yuan in Rare Metals (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12598-021-01789-y.pdf

5. Increased psychological distress after the lifting of COVID-19 lockdown in the Saudi population: a cross-sectional study

Hatim Yousef Alharbi, Sami S. Alharthi… in Middle East Current Psychiatry (2022)

https://link.springer.com/content/pdf/10.1186%2Fs43045-021-00167-9.pdf

6. The impact of COVID-19 on surgical procedures in Japan: analysis of data from the National Clinical Database

Norihiko Ikeda, Hiroyuki Yamamoto, Akinobu Taketomi, Taizo Hibi… in Surgery Today (2022)

https://link.springer.com/content/pdf/10.1007%2Fs00595-021-02406-2.pdf

7. The moderating effect of solar radiation on the association between human mobility and COVID-19 infection in Europe